News

We sit down in a video interview with David Pariser, MD, FACP, FAAD, the secretary and founding member of the International Hyperhidrosis Society to discuss hyperhidrosis identifiers and treatments in honor of Hyperhidrosis Awareness Month.

Click here to answer this weeks poll.

A preview at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes an exclusive interview the NFCMMD symposium, and articles on ruxolitinib, what to watch in the psoriasis pipeline, and more.

The assumption has been that the COVID-19 pandemic has been at the root of recent upticks in physician burnout.

This week’s edition of The Mainstream Patient features stories about psoriasis complications, what milia is and more!

A preview at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes an exclusive interview about eczema, and articles on a new tralokinumab data, apremilast as a combination treatment, and more.

This week’s edition of The Mainstream Patient features stories about how biologic treatments changed 6 psoriasis patients lives, updated sunscreen regulations, and more!

A preview at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes an exclusive interview about tralokinumab, and articles on ruxolitinib as a treatment for vitiligo, the role of diet in acne and more.

Bayer is recalling its Lotrimin AF and Tinactin spray products due to the presence of the carcinogen benzene.

Coppertone, David Light, founder and CEO of Valisure, and Christopher Bunick, MD, PhD, share their thoughts on the sunscreen giant’s voluntary recall of 12 lots of its aerosol sunscreen after finding the presence of benzene.

The two companies are using their DREAM initiative to support the diverse dermatology index.

This week’s edition of The Mainstream Patient features stories about skin cancer, a new app developed to diagnose skin issues, and more!

Click here to answer our weekly poll.

A preview at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes a new podcast episode on type 2 inflammation, and articles on Maui Derm NP+PA Fall 2021, the role of nutrition in wound care and more.

The Cosmetic Bootcamp is being held in Chicago, Illinois, December 11, 2021. The agenda for the event contains live patient demos and more.

Read this article to see what is being covered at the Science of Skincare annual meeting being held in New York, New York, on November 6, 2021.

Dermatology Times® welcomes 7 new members to its Editorial Advisory Board

The 11th annual New Frontiers in Cosmetic Medicine & Medical Dermatology Symposium agenda has been released. Click to see what this meeting has to offer.

In this week’s Pointers with Dr Portela, the 208SkinDoc compares 3 different fluid sunscreens to decided, in his opinion, which works best.

The EADV has revealed the findings from a recent survey shows almost half of all European adults have a dermatological condition.

This week’s edition of The Mainstream Patient features stories about HS flares during the period, clothes that double as skincare, and more!

Click here to answer our weekly poll.

Patients with skin conditions may be more likely to contract the disease but less likely to become severely ill.

A glimpse at what to expect from Dermatology Times this week.

In a grand rounds presentation at the Maui Derm NP+PA Fall 2021 conference, Seemal Desai, MD, FAAD, Raegan Hunt, MD, PhD, Ted Rosen, MD, and Matthew J. Zirwas, MD, discussed some of their challenging cases.

Learning to identify some well-disguised drivers of eczema and contact dermatitis can speed patients toward clear or almost clear, according to a presentation at Maui Derm NP+PA Fall 2021.